Estrogen Receptor, Progesterone Receptor, and HER2-neu Expression in First Primary Breast Cancers and Risk of Second Primary Contralateral Breast Cancer

Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-012-2183-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Estrogen Receptor and HER2/neu Status Affect Epigenetic Differences of Tumor-Related Genes in Primary Breast Tumors

Breast Cancer Research
Cancer ResearchOncology
2008English

Estrogen Receptor (ER) mRNA Expression and Molecular Subtype Distribution in ER-negative/progesterone Receptor-Positive Breast Cancers

Breast Cancer Research and Treatment
Cancer ResearchOncology
2013English

Estrogen and HER-2 Receptor Discordance Between Primary Breast Cancer and Metastasis

Oncologist
Cancer ResearchMedicineOncology
2010English

Alcohol, Smoking, and Risk of Her2-Overexpressing and Triple-Negative Breast Cancer Relative to Estrogen Receptor-Positive Breast Cancer

International Journal of Cancer
Cancer ResearchOncology
2018English

Intraocular Metastases Secondary to Breast Carcinoma Correlates With Upregulation of Estrogen and Progesterone Receptor Expression in the Primary Tumor

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2016English

Expression of Estrogen and Progesterone Receptor Status in Breast Carcinoma Using Quick Score

Annals of Pathology and Laboratory Medicine
2018English

Somatostatin-Receptor Scintigraphy in Primary Breast Cancer

The Lancet
Medicine
1994English

Progesterone Receptor Expression in Proliferating Cancer Cells of Hormone-Receptor-Positive Breast Cancer

Tumor Biology
MedicineCancer Research
2018English

Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance Between Immuno-Histochemistry and MapQuant™ Microarray Based Assay

PLoS ONE
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy